Verification of Alternative Do-it-yourself Equipment Respirators for the COVID-19 Personal Protective Equipment (PPE) (VADER)

Verification of Alternative Do-it-yourself Equipment Respirators

The COVID-19 pandemic health crisis forces health institutions to lower their standards of protection as supplies of personal protective equipment decrease despite the safety of front-line workers worldwide . This shortage specifically affects high-quality protective masks, such as those called FFP2. As alternatives, we offer a reusable mask based on a ventilation mask combined with a breathing filter for anesthesia breathing circuits. The purpose of the study is to assess the sealing potential of this mask in the field and possibly prove a non-inferior sealing compared to standard masks type FFP2.

Study Overview

Status

Unknown

Conditions

Detailed Description

The ongoing 2020 COVID-19 pandemic challenges healthcare providers (HCP) worldwide with a rapid consumption and shortage of personal protection equipment (PPE), especially high-level filtration respirator masks. Respirators used by HCPs are mainly single use face filtering pieces with at least level P2 protection for single shift use following European EN 149 standards defining protection level against hazardous particles.

In response to the risk of shortage we propose a novel reusable do-it-yourself (DIY) respirator assembled with already widely available components in hospital stocks: a standard breathing filter plugged in an anaesthesia facial mask held in place with a hook ring strapped to a silicone head harness. As reports of a modified full-face snorkelling (MFS) mask used for non-invasive ventilation in infected patients emerged in Italy, we reckon that it could also be used as PPE with a modified valve and breathing filter.

Study Type

Interventional

Enrollment (Anticipated)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brussels, Belgium, 1200
        • Recruiting
        • Cliniques Universitaires Saint-Luc
        • Contact:
          • Marco Pettinger, MD
          • Phone Number: 00352 661 90 20 39
          • Email: marco@msg.lu
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • adult volunteers working in a first line healthcare service with basic knowledge of donning PPE including respirators
  • 5 females and 5 males

Exclusion Criteria:

  • smoking or unhealthy participants with respiratory affections to avoid breathing difficulties during testing
  • any known allergy towards medical silicone or any other material of each component and ingredients used for disinfection of the test area and material between participants

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: NON_RANDOMIZED
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
OTHER: FFP2
Face Fit test of the FFP2 with the PortaCount® PRO+ 8038 from TSI
OTHER: Facial mask
Face Fit test of a conventional respirator facial mask with the PortaCount® PRO+ 8038 from TSI
OTHER: Modified full-face snorkeling
Face fit test of a MFS with the PortaCount® PRO+ 8038 from TSI

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of airtightness (Fit test)
Time Frame: Up to 1 week
Non inferiority claim over FFP2
Up to 1 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
User Comfort
Time Frame: Up to 1 week
User face comfort for each type of mask assessed by a assessed by a scoring-cale from 1 to 5
Up to 1 week
Breathing easiness
Time Frame: Up to 1 week
User respiratory easiness for each type of mask assessed by a scoring-cale from 1 to 5
Up to 1 week
Field of view quality
Time Frame: Up to 1 week
User field of view quality for each type of mask assessed by a scoring-cale from 1 to 5
Up to 1 week
Ease of use
Time Frame: Up to 1 week
How the device is user friendly, assessed by a scoring-cale from 1 to 5
Up to 1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Guillaume Lemaire, MD, Cliniques Universitaires Saint-Luc

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

May 1, 2020

Primary Completion (ANTICIPATED)

May 1, 2020

Study Completion (ANTICIPATED)

May 1, 2020

Study Registration Dates

First Submitted

April 17, 2020

First Submitted That Met QC Criteria

May 4, 2020

First Posted (ACTUAL)

May 5, 2020

Study Record Updates

Last Update Posted (ACTUAL)

May 5, 2020

Last Update Submitted That Met QC Criteria

May 4, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 2020/15AVR/226

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

All data will be presented in the future manuscript

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe